Page last updated: 2024-09-05

anidulafungin and tigecycline

anidulafungin has been researched along with tigecycline in 3 studies

Compound Research Comparison

Studies (anidulafungin)	Trials (anidulafungin)	Recent Studies (post-2010) (anidulafungin)	Studies (tigecycline)	Trials (tigecycline)	Recent Studies (post-2010) (tigecycline)
568	33	331	1,999	68	1,285

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Holtappels, M; Kucharíková, S; Lagrou, K; Lamkanfi, M; Rogiers, O; Siala, W; Van Bambeke, F; Van Dijck, P	1

Reviews

1 review(s) available for anidulafungin and tigecycline

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for anidulafungin and tigecycline

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies. The Journal of antimicrobial chemotherapy, 2018, 10-01, Volume: 73, Issue:10 Topics: Anidulafungin; Animals; Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Coinfection; Disease Models, Animal; Drug Synergism; Flow Cytometry; Foreign Bodies; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Treatment Outcome	2018

Article

Year

Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.

Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008

Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies.

The Journal of antimicrobial chemotherapy, 2018, 10-01, Volume: 73, Issue:10

Topics: Anidulafungin; Animals; Anti-Bacterial Agents; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Coinfection; Disease Models, Animal; Drug Synergism; Flow Cytometry; Foreign Bodies; Mice, Inbred BALB C; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Peritonitis; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Treatment Outcome

2018